Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis
Clinical trial NCT03824392 · COMPLETED
Trial details
- NCT number
- NCT03824392
- Sponsor
- aTyr Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-29
- Primary completion
- 2021-06-29
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.